Rapport Therapeutics announced the pricing of underwritten public offerings totaling approximately $175 million in common stock and $150 million in convertible senior notes, along with a concurrent $30 million private placement. The proceeds will primarily fund ongoing and planned clinical trials for their lead drug RAP-219 targeting neurological disorders, as well as other research and general corporate needs. The offerings are expected to close around October 30, 2026, and the company believes the funds will support operations through the end of 2029. Convertible notes carry a 2.25% interest rate and mature in 2032, with options for early conversion and redemption under specified conditions.
Rapport Therapeutics' recent financing activities provide context for readers following health-sector stocks. For readers following health-sector stocks, here is Pluang's market snapshot as of Oct 28, 2026 16:41 WIB: out of 150 priced US health stocks, 47 rose and 92 fell. GSK traded at USD 49.05 with a 1-day change of -3.71%, Axogen Inc was at USD 36.52 with a -2.51% change, and Sana Biotechnology Inc rose 2.43% to USD 2.53 with 69% buy activity on Pluang.
Stella-Jones Inc. announced that its CEO Eric Vachon and CFO Silvana Travaglini will participate in the RBC Capital Markets 2026 Global Industrials Conference in New York on November 16, 2026. The company will hold meetings with institutional investo...
Xunce has launched TokenRouters, a platform designed as a one-stop hub for exchanging AI data and specialized tokens to optimize enterprise AI models. The platform addresses the challenge of matching AI resources by integrating datasets, models, appl...
Stella-Jones Inc. announced that its CEO Éric Vachon and CFO Silvana Travaglini will attend the RBC Capital Markets 2026 Global Industrial Products Conference in New York on November 16, 2026. They will meet with institutional investors to discuss th...
Copenhagen Airports has named Sofie Mørck Jarl as its new Chief Financial Officer, effective by March 1, 2027. She previously held senior finance roles at Novo Nordisk and brings experience in strategy, financial leadership, and managing large invest...
Prophecy introduced DataGPT, a new AI tool that enables business data analysts to perform full data workflows—from messy data onboarding to final report publishing—directly within ChatGPT, Claude, and Microsoft Copilot. DataGPT generates visual workf...
